These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 30968395)
1. Dermatofibrosarcoma protuberans with fibrosarcomatous transformation: our experience, molecular evaluation of selected cases, and short literature review. Lopez LV; Yatsenko SA; Burgess M; Schoedel K; Rao UNM Int J Dermatol; 2019 Nov; 58(11):1246-1252. PubMed ID: 30968395 [TBL] [Abstract][Full Text] [Related]
2. Dermatofibrosarcoma Protuberans: A Clinicopathologic and Therapeutic Analysis of 254 Cases at a Single Institution. Jing C; Zhang H; Zhang X; Yu S Dermatol Surg; 2021 Feb; 47(2):e26-e30. PubMed ID: 32769521 [TBL] [Abstract][Full Text] [Related]
3. PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications. Ha SY; Lee SE; Kwon MJ; Kim YJ; Lee EH; Seo J; Jang KT; Lee J; Choi YL Hum Pathol; 2013 Jul; 44(7):1300-9. PubMed ID: 23347652 [TBL] [Abstract][Full Text] [Related]
4. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans. Hisaoka M; Okamoto S; Morimitsu Y; Tsuji S; Hashimoto H Virchows Arch; 1998 Oct; 433(4):323-9. PubMed ID: 9808434 [TBL] [Abstract][Full Text] [Related]
5. A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change. Liang CA; Jambusaria-Pahlajani A; Karia PS; Elenitsas R; Zhang PD; Schmults CD J Am Acad Dermatol; 2014 Oct; 71(4):781-6. PubMed ID: 24755121 [TBL] [Abstract][Full Text] [Related]
6. PDGFB Rearrangements in Dermatofibrosarcoma Protuberans of the Vulva: A Study of 11 Cases Including Myxoid and Fibrosarcomatous Variants. Jahanseir K; Xing D; Greipp PT; Sukov WR; Keeney GL; Howitt BE; Schoolmeester JK Int J Gynecol Pathol; 2018 Nov; 37(6):537-546. PubMed ID: 29140881 [TBL] [Abstract][Full Text] [Related]
7. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution. DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497 [TBL] [Abstract][Full Text] [Related]
8. [Dermatofibrosarcoma: Management]. Penel N; El Bedoui S; Robin YM; Decanter G Bull Cancer; 2018 Nov; 105(11):1094-1101. PubMed ID: 30297237 [TBL] [Abstract][Full Text] [Related]
9. [Fibrosarcomatous dermatofibrosarcoma protuberans: a clinicopathological analysis of 12 cases]. Zhang J; Wu N; Xia C; Wei X; Shi QL; Zhou XJ; Ma J Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):753-7. PubMed ID: 24447553 [TBL] [Abstract][Full Text] [Related]
10. Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation. Rutkowski P; Klimczak A; Ługowska I; Jagielska B; Wągrodzki M; Dębiec-Rychter M; Pieńkowska-Grela B; Świtaj T Eur J Surg Oncol; 2017 Jun; 43(6):1134-1141. PubMed ID: 28365129 [TBL] [Abstract][Full Text] [Related]
11. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors. Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152 [TBL] [Abstract][Full Text] [Related]
12. Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans. Kiuru-Kuhlefelt S; El-Rifai W; Fanburg-Smith J; Kere J; Miettinen M; Knuutila S Cytogenet Cell Genet; 2001; 92(3-4):192-5. PubMed ID: 11435686 [TBL] [Abstract][Full Text] [Related]
13. Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial-Mesenchymal Transition-like Process and 22q Loss. Stacchiotti S; Astolfi A; Gronchi A; Fontana A; Pantaleo MA; Negri T; Brenca M; Tazzari M; Urbini M; Indio V; Colombo C; Radaelli S; Brich S; Dei Tos AP; Casali PG; Castelli C; Dagrada GP; Pilotti S; Maestro R Mol Cancer Res; 2016 Sep; 14(9):820-9. PubMed ID: 27256159 [TBL] [Abstract][Full Text] [Related]